Department for Urology

Publications

  1. High BCAR1 expression is associated with early PSA recurrence in ERG negative prostate cancer

    Heumann, A., Heinemann, N., Hube-Magg, C., Lang, D. S., Grupp, K., Kluth, M., Minner, S., Möller-Koop, C., Graefen, M., Heinzer, H., Tsourlakis, M. C., Wilczak, W., Wittmer, C., Jacobsen, F., Huland, H., Simon, R., Schlomm, T., Sauter, G., Steurer, S., Lebok, P. & Hinsch, A., 05.01.2018, In: BMC CANCER. 18, 1, p. 37

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  2. High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy

    Mandel, P., Preisser, F., Graefen, M., Steuber, T., Salomon, G., Haese, A., Michl, U., Huland, H. & Tilki, D., 06.2017, In: EUR UROL. 71, 6, p. 848-850

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancer

    Eichenauer, T., Federlein, F., Möller, K., Chirico, V., Kind, S., Lennartz, M., Lutz, F., Hube-Magg, C., Höflmayer, D., Fisch, M., Huland, H., Heinzer, H., Graefen, M., Haese, A., Schroeder, C., Lebok, P., Minner, S., Simon, R., Sauter, G., Schlomm, T., Wilczak, W., Steurer, S. & Luebke, A. M., 06.2020, In: PATHOLOGY. 52, 4, p. 421-430 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer.

    Jacobsen, F., Ashtiani, S. N., Tennstedt, P., Heinzer, H., Simon, R., Sauter, G., Sirma, H., Tsourlakis, M. C., Minner, S. J. P., Schlomm, T. & Michl, U., 2013, In: EXP THER MED. 5, 1, p. 102-106 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens

    Steurer, S., Rico, S. D., Simon, R., Minner, S., Tsourlakis, M. C., Krech, T., Koop, C., Graefen, M., Heinzer, H., Adam, M., Huland, H., Schlomm, T., Sauter, G. & Lumiani, A., 09.2017, In: BJU INT. 120, 3, p. 365-376 12 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.

    Schmitges, J., Trinh, Q-D., Sun, M., Hansen, J., Bianchi, M., Jeldres, C., Perrotte, P., Dahlem, R., Shariat, S. F., Chun, F., Montorsi, F., Menon, M., Fisch, M., Graefen, M. & Karakiewicz, P. I., 2012, In: BJU INT. 110, 6 Pt B, p. 183-190 6 Pt B.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.

    Walz, J., Graefen, M., Chun, F. K-H., Erbersdobler, A., Haese, A., Steuber, T., Schlomm, T., Huland, H. & Karakiewicz, P. I., 2006, In: EUR UROL. 50, 3, p. 498-505 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. High-Level Glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer

    Burdelski, C., Shihada, R., Hinsch, A., Angerer, A., Göbel, C., Friedrich, E., Hube-Magg, C., Burdak-Rothkamm, S., Kluth, M., Simon, R., Möller-Koop, C., Sauter, G., Büscheck, F., Wittmer, C., Clauditz, T. S., Krech, T., Tsourlakis, M. C., Minner, S., Graefen, M., Schlomm, T., Wilczak, W. & Jacobsen, F., 11.2017, In: PROSTATE. 77, 15, p. 1528-1538 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. High-Level HOOK3 Expression Is an Independent Predictor of Poor Prognosis Associated with Genomic Instability in Prostate Cancer

    Melling, N., Harutyunyan, L., Hube-Magg, C., Kluth, M., Simon, R., Lebok, P., Minner, S., Tsourlakis, M. C., Koop, C., Graefen, M., Adam, M., Haese, A., Wittmer, C., Steurer, S., Izbicki, J., Sauter, G., Wilczak, W., Schlomm, T. & Krech, T., 2015, In: PLOS ONE. 10, 7, p. e0134614

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. High level of Ets-related gene expression has high specificity for prostate cancer: a tissue microarray study of 11 483 cancers.

    Minner, S. J. P., Lübke, A., Kluth, M., Bokemeyer, C., Jänicke, F., Izbicki, J. R., Schlomm, T., Sauter, G. & Wilczak, W., 01.09.2012, In: HISTOPATHOLOGY. 61, 3, p. 445-453 9 p., 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  11. High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma

    Eichenauer, T., Simmendinger, L., Fraune, C., Mandelkow, T., Blessin, N. C., Kluth, M., Hube-Magg, C., Möller, K., Clauditz, T., Weidemann, S., Dahlem, R., Fisch, M., Riechardt, S., Simon, R., Sauter, G., Büscheck, F. & Rink, M., 02.2021, In: WORLD J UROL. 39, 2, p. 481-490 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

    Minner, S. J. P., Wittmer, C., Graefen, M., Salomon, G., Steuber, T., Haese, A., Huland, H., Bokemeyer, C., Yekebas, E. F., Dierlamm, J., Balabanov, S., Kilic, E., Wilczak, W., Simon, R., Sauter, G. & Schlomm, T., 2011, In: PROSTATE. 71, 3, p. 281-288 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. High-Level γ-Glutamyl-Hydrolase (GGH) Expression is Linked to Poor Prognosis in ERG Negative Prostate Cancer

    Melling, N., Rashed, M., Schroeder, C., Hube-Magg, C., Kluth, M., Lang, D., Simon, R., Möller-Koop, C., Steurer, S., Sauter, G., Jacobsen, F., Büscheck, F., Wittmer, C., Clauditz, T., Krech, T., Tsourlakis, M. C., Minner, S., Huland, H., Graefen, M., Budäus, L., Thederan, I., Salomon, G., Schlomm, T. & Wilczak, W., 29.01.2017, In: INT J MOL SCI. 18, 2, p. 286

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.

    Jeldres, C., Sun, M., Lughezzani, G., Isbarn, H., Shariat, S. F., Widmer, H., Graefen, M., Montorsi, F., Perrotte, P. & Karakiewicz, P. I., 2010, In: CANCER-AM CANCER SOC. 116, 16, p. 3774-3784 16.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma

    Kumar, P., Nandi, S., Tan, T. Z., Ler, S. G., Chia, K. S., Lim, W-Y., Bütow, Z., Vordos, D., De la Taille, A., Al-Haddawi, M., Raida, M., Beyer, B., Ricci, E., Colombel, M., Chong, T. W., Chiong, E., Soo, R., Park, M. K., Ha, H. K., Gunaratne, J. & Thiery, J. P., 30.05.2015, In: ONCOTARGET. 6, 15, p. 13539-49 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers

    Grupp, K., Sanader, S., Sirma, H., Simon, R., Koop, C., Prien, K., Hube-Magg, C., Salomon, G., Graefen, M., Heinzer, H., Minner, S., Izbicki, J. R., Sauter, G., Schlomm, T. & Tsourlakis, M. C., 01.12.2013, In: MOL ONCOL. 7, 6, p. 1001-11 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. High mitochondria content is associated with prostate cancer disease progression

    Grupp, K., Jedrzejewska, K., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Quaas, A., Sauter, G., Simon, R., Izbicki, J. R., Graefen, M., Huland, H., Schlomm, T., Minner, S. & Steurer, S., 01.01.2013, In: MOL CANCER. 12, 1, p. 145

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. High Nr-CAM expression is associated with favorable phenotype and late PSA recurrence in prostate cancer treated by prostatectomy

    Tsourlakis, M. C., Delmo Walter, E. M., Quaas, A., Graefen, M., Huland, H., Simon, R., Sauter, G., Steurer, S., Schlomm, T. & Minner, S., 01.06.2013, In: PROSTATE CANCER P D. 16, 2, p. 159-64 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. High nuclear karyopherin α 2 expression is a strong and independent predictor of biochemical recurrence in prostate cancer patients treated by radical prostatectomy

    Grupp, K., Habermann, M., Sirma, H., Simon, R., Steurer, S., Hube-Magg, C., Prien, K., Burkhardt, L., Jedrzejewska, K., Salomon, G., Heinzer, H., Wilczak, W., Kluth, M., Izbicki, J. R., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.01.2014, In: MODERN PATHOL. 27, 1, p. 96-106 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.

    Jeldres, C., Suardi, N., Saad, F., Montorsi, F., Shariat, S. F., Perrotte, P., Bhojani, N., Walz, J., Hutterer, G. C., Graefen, M., Valiquette, L. & Karakiewicz, P. I., 2008, In: EUR UROL. 54, 1, p. 97-105 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. High RNA-binding motif protein 3 expression is an independent prognostic marker in operated prostate cancer and tightly linked to ERG activation and PTEN deletions

    Grupp, K., Wilking, J., Prien, K., Hube-Magg, C., Sirma, H., Simon, R., Steurer, S., Budäus, L., Haese, A., Izbicki, J., Sauter, G., Minner, S., Schlomm, T. & Tsourlakis, M. C., 01.03.2014, In: EUR J CANCER. 50, 4, p. 852-61 10 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer.

    Jeldres, C., Nazareno, S., Capitanio, U., Montorsi, F., Shariat, S. F., Perrotte, P., Peloquin, F., Pharand, D., Graefen, M. & Karakiewicz, P. I., 2008, In: BJU INT. 102, 4, p. 463-467 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. High tissue density of FOXP3+ T cells is associated with clinical outcome in prostate cancer

    Flammiger, A., Weisbach, L., Huland, H., Tennstedt, P., Simon, R., Minner, S., Bokemeyer, C., Sauter, G., Schlomm, T. & Trepel, M., 01.04.2013, In: EUR J CANCER. 49, 6, p. 1273-9 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Hispanic vs. Caucasian Race/Ethnicity in Adrenocortical Carcinoma Patients

    Panunzio, A., Tappero, S., Garcia, C. C., Piccinelli, M., Barletta, F., Incesu, R-B., Tian, Z., Tafuri, A., Tilki, D., Briganti, A., DE Cobelli, O., Chun, F. K. H., Terrone, C., Saad, F., Shariat, S. F., Bourdeau, I., Cerruto, M. A., Antonelli, A. & Karakiewicz, P. I., 11.2022, In: ANTICANCER RES. 42, 11, p. 5579-5585 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Histologically Confirmed Diagnostic Efficacy of 18F-rhPSMA-7 PET for N-Staging of Patients with Primary High-Risk Prostate Cancer

    Kroenke, M., Wurzer, A., Schwamborn, K., Ulbrich, L., Jooß, L., Maurer, T., Horn, T., Rauscher, I., Haller, B., Herz, M., Wester, H-J., Weber, W. A. & Eiber, M., 05.2020, In: J NUCL MED. 61, 5, p. 710-715 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Histologic variants of upper tract urothelial carcinoma do not affect response to adjuvant chemotherapy after radical nephroureterectomy.

    Xylinas, E., Rink, M., Margulis, V., Karakiewicz, P. I., Bensalah, K., Shariat, S. F. & Collaboration, U. T. U. C., 2012, In: EUR UROL. 62, 1, p. 25-26 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Histopathological Characteristics of Buccal Mucosa Transplants in Humans after Engraftment to the Urethra: A Prospective Study

    Soave, A., Steurer, S., Dahlem, R., Rink, M., Reiss, P., Fisch, M. & Engel, O., 01.12.2014, In: J UROLOGY. 192, 6, p. 1725-9 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Histopathological results of radical prostatectomy specimen of men younger than 50 years of age at the time of surgery: possible implications for prostate cancer screening programs?

    Mehring, G., Tilki, D., Heinzer, H., Steuber, T., Pose, R. M., Thederan, I., Budäus, L., Salomon, G., Haese, A., Michl, U., Maurer, T., Huland, H., Graefen, M. & Isbarn, H., 02.2023, In: WORLD J UROL. 41, 2, p. 421-425 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Holmium laser enucleation of the prostate is safe in patients with prostate cancer and lower urinary tract symptoms--a retrospective feasibility study

    Becker, A., Placke, A., Kluth, L., Schwarz, R., Isbarn, H., Chun, F., Heuer, R., Schlomm, T., Seiler, D., Engel, O., Fisch, M., Graefen, M. & Ahyai, S. A., 01.03.2014, In: J ENDOUROL. 28, 3, p. 335-41 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Holmium laser enucleation of the prostate versus open prostatectomy for prostates greater than 100 grams: 5-year follow-up results of a randomised clinical trial.

    Kuntz, R. M., Lehrich, K. & Ahyai, S., 2008, In: EUR UROL. 53, 1, p. 160-166 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Holmium laser enucleation versus transurethral resection of the prostate: 3-year follow-up results of a randomized clinical trial.

    Ahyai, S., Lehrich, K. & Kuntz, R. M., 2007, In: EUR UROL. 52, 5, p. 1456-1463 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.

    Abdollah, F., Schmitges, J., Sun, M., Thuret, R., Djahangirian, O., Jeldres, C., Shariat, S. F., Graefen, M., Perrotte, P., Montorsi, F. & Karakiewicz, P. I., 2011, In: J UROLOGY. 186, 3, p. 824-828 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study

    Groeben, C., Boehm, K., Koch, R., Sonntag, U., Nestler, T., Struck, J., Heck, M., Baunacke, M., Uhlig, A., Koelker, M., Meyer, C. P., Becker, B., Salem, J., Huber, J. & Leitsmann, M., 02.2023, In: WORLD J UROL. 41, 2, p. 601-609 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy.

    Sun, M., Bianchi, M., Trinh, Q-D., Abdollah, F., Schmitges, J., Jeldres, C., Shariat, S. F., Graefen, M., Montorsi, F., Perrotte, P. & Karakiewicz, P. I., 2012, In: J UROLOGY. 187, 2, p. 405-410 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. How can we improve surgical outcomes?

    Hanske, J., Meyer, C. P. & Trinh, Q-D., 12.2015, In: BJU INT. 116, 6, p. 835-6 2 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearch

  36. How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis

    Siltari, A., Lönnerbro, R., Pang, K., Shiranov, K., Asiimwe, A., Evans-Axelsson, S., Franks, B., Kiran, A., Murtola, T. J., Schalken, J., Steinbeisser, C., Bjartell, A., Auvinen, A. & PIONEER Consortium, 04.2023, In: CLIN GENITOURIN CANC. 21, 2, p. 316.e1-316.e11

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  37. HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy

    Zabalza, C. V., Adam, M., Burdelski, C., Wilczak, W., Wittmer, C., Kraft, S., Krech, T., Steurer, S., Koop, C., Hube-Magg, C., Graefen, M., Heinzer, H., Minner, S., Simon, R., Sauter, G., Schlomm, T. & Tsourlakis, M. C., 23.03.2015, In: ONCOTARGET. 6, 14, p. 12822-12834

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. HPV status in patients with head and neck of carcinoma of unknown primary site: HPV, tobacco smoking, and outcome.

    Tribius, S., Hoffmann, A. S., Bastrop, S., Görögh, T., Haag, J., Röcken, C., Clauditz, T., Grob, T., Wilczak, W., Tennstedt, P., Borcherding, A., Petersen, C. & Hoffmann, M., 2012, In: ORAL ONCOL. 48, 11, p. 1178-1184 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.

    Haese, A., Becker, C., Noldus, J., Graefen, M., Huland, E., Huland, H. & Lilja, H., 2000, In: J UROLOGY. 163, 5, p. 1491-1497 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  40. Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.

    Haese, A., Graefen, M., Steuber, T., Becker, C., Pettersson, K., Piironen, T., Noldus, J., Huland, H. & Lilja, H., 2001, In: PROSTATE. 49, 2, p. 101-109 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Human prostate cancer in a clinically relevant xenograft mouse model: identification of β(1,6)-branched oligosaccharides as a marker of tumor progression.

    Lange, T., Ullrich, S., Müller, I., Nentwich, M., Stübke, K., Feldhaus, S., Knies, C., Hellwinkel, O., Vessella, R. L., Abramjuk, C., Anders, M., Schröder-Schwarz, J., Schlomm, T., Huland, H., Sauter, G. & Schumacher, U., 2012, In: CLIN CANCER RES. 18, 5, p. 1364-1373 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. [Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]

    Hautmann, S. H., Schroeder, G. L., Civantos, F., Duncan, R. C., Gnann, R., Friedrich, M., Hellstern, A., Huland, H., Soloway, M. S. & Lokeshwar, V. B., 2001, In: UROLOGE. 40, 2, p. 121-126 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Hyospadie

    Soave, A., Rink, M. & Fisch, M., 2014, Facharztwissen Urologie: Differenzierte Diagnostik und Therapie. Schmelz, H-U., Sparwasser, C. & Weidner, W. (eds.). 3 ed. Springer, p. 353-358 6 p.

    Research output: SCORING: Contribution to book/anthologySCORING: Contribution to collected editions/anthologiesEducationpeer-review

  44. Iatrogenic ureteric injury during abdominal or pelvic surgery: a meta-analysis

    Yanagisawa, T., Mori, K., Quhal, F., Kawada, T., Mostafaei, H., Laukhtina, E., Rajwa, P., Sari Motlagh, R., Aydh, A., König, F., Pallauf, M., Pradere, B., Miki, J., Kimura, T., Egawa, S. & Shariat, S. F., 05.2023, In: BJU INT. 131, 5, p. 540-552 13 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  45. [Identification and validation of clinically relevant molecular alterations in prostate cancer]

    Schlomm, T., Sültmann, H. & Köllermann, J., 2008, In: UROLOGE. 47, 9, p. 1193-1198 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Identification of Clinically Relevant Protein Targets in Prostate Cancer with 2D-DIGE Coupled Mass Spectrometry and Systems Biology Network Platform.

    Ummanni, R., Mundt, F., Pospisil, H., Venz, S., Scharf, C., Barett, C., Fälth, M., Köllermann, J., Walther, R., Schlomm, T., Sauter, G., Bokemeyer, C., Sültmann, H., Schuppert, A., Brümmendorf, T. & Balabanov, S., 2011, In: PLOS ONE. 6, 2, p. 16833 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Identification of pathologically favorable disease in intermediate-risk prostate cancer patients: Implications for active surveillance candidates selection

    Gandaglia, G., Schiffmann, J., Schlomm, T., Fossati, N., Moschini, M., Suardi, N., Chun, F. K. H., Montorsi, F., Graefen, M. & Briganti, A., 09.2015, In: PROSTATE. 75, 13, p. 1484-91 8 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.

    Briganti, A., Joniau, S., Gontero, P., Abdollah, F., Passoni, N. M., Tombal, B., Marchioro, G., Kneitz, B., Walz, J., Frohneberg, D., Bangma, C. H., Graefen, M., Tizzani, A., Frea, B., Karnes, R. J., Montorsi, F., Hein, V. P. & Spahn, M., 2012, In: EUR UROL. 61, 3, p. 584-592 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Identifying the Most Informative Prediction Tool for Cancer-specific Mortality After Radical Prostatectomy: Comparative Analysis of Three Commonly Used Preoperative Prediction Models

    Böhm, K., Larcher, A., Beyer, B., Tian, Z., Tilki, D., Steuber, T., Karakiewicz, P. I., Heinzer, H., Graefen, M. & Budäus, L., 01.06.2016, In: EUR UROL. 69, 6, p. 1038-43

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. IL-33-Mediated Expansion of Type 2 Innate Lymphoid Cells Protects from Progressive Glomerulosclerosis

    Riedel, J-H., Becker, M., Kopp, K., Düster, M., Brix, S. R., Meyer-Schwesinger, C., Kluth, L. A., Gnirck, A-C., Attar, M., Krohn, S., Fehse, B., Stahl, R. A. K., Panzer, U. & Turner, J-E., 07.2017, In: J AM SOC NEPHROL. 28, 7, p. 2068-2080

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review